Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATNM |
---|---|---|
09:32 ET | 11890 | 7.34 |
09:36 ET | 419 | 7.375 |
09:38 ET | 4041 | 7.35 |
09:39 ET | 600 | 7.35 |
09:45 ET | 867 | 7.3 |
09:48 ET | 688 | 7.211 |
09:50 ET | 600 | 7.2 |
09:52 ET | 278 | 7.16 |
09:54 ET | 100 | 7.16 |
09:56 ET | 955 | 7.29 |
09:57 ET | 7000 | 7.2101 |
09:59 ET | 1750 | 7.2 |
10:01 ET | 815 | 7.2012 |
10:03 ET | 1550 | 7.1701 |
10:06 ET | 6341 | 7.19 |
10:12 ET | 1220 | 7.06 |
10:14 ET | 1495 | 7.0877 |
10:17 ET | 700 | 7.0779 |
10:19 ET | 1200 | 7.15 |
10:24 ET | 100 | 7.15 |
10:26 ET | 3137 | 7.13 |
10:28 ET | 12600 | 7.17 |
10:30 ET | 300 | 7.17 |
10:32 ET | 8635 | 7.18 |
10:33 ET | 5999 | 7.23 |
10:35 ET | 1680 | 7.21 |
10:37 ET | 9900 | 7.16 |
10:39 ET | 200 | 7.18 |
10:42 ET | 4118 | 7.14 |
10:44 ET | 14998 | 7.1609 |
10:46 ET | 4929 | 7.09 |
10:50 ET | 1000 | 7.115 |
10:51 ET | 100 | 7.14 |
10:53 ET | 200 | 7.1214 |
10:55 ET | 1337 | 7.09 |
10:57 ET | 1900 | 7.14 |
11:08 ET | 500 | 7.15 |
11:15 ET | 300 | 7.13 |
11:20 ET | 3203 | 7.09 |
11:29 ET | 996 | 7.08 |
11:31 ET | 1900 | 7.08 |
11:33 ET | 300 | 7.09 |
11:36 ET | 100 | 7.08 |
11:38 ET | 1942 | 7.08 |
11:40 ET | 600 | 7.07 |
11:42 ET | 540 | 7.08 |
11:49 ET | 1500 | 7.07 |
11:54 ET | 100 | 7.08 |
12:02 ET | 2721 | 7.08 |
12:03 ET | 100 | 7.0999 |
12:05 ET | 1718 | 7.1 |
12:12 ET | 1870 | 7.15 |
12:18 ET | 1099 | 7.125 |
12:20 ET | 838 | 7.12 |
12:27 ET | 100 | 7.14 |
12:32 ET | 1210 | 7.115 |
12:41 ET | 500 | 7.09 |
12:50 ET | 904 | 7.11 |
12:54 ET | 1200 | 7.12 |
12:56 ET | 100 | 7.14 |
01:06 ET | 100 | 7.12 |
01:21 ET | 100 | 7.13 |
01:30 ET | 100 | 7.125 |
01:33 ET | 2895 | 7.165 |
01:35 ET | 700 | 7.13 |
01:42 ET | 600 | 7.11 |
01:48 ET | 100 | 7.09 |
01:51 ET | 1799 | 7.11 |
01:57 ET | 500 | 7.09 |
02:02 ET | 100 | 7.12 |
02:08 ET | 1050 | 7.155 |
02:15 ET | 300 | 7.16 |
02:18 ET | 214 | 7.14 |
02:20 ET | 550 | 7.1488 |
02:24 ET | 300 | 7.1301 |
02:27 ET | 649 | 7.135 |
02:29 ET | 100 | 7.17 |
02:47 ET | 1822 | 7.17 |
02:49 ET | 258 | 7.18 |
02:51 ET | 400 | 7.2 |
02:56 ET | 100 | 7.22 |
03:02 ET | 200 | 7.1931 |
03:03 ET | 300 | 7.18 |
03:16 ET | 175 | 7.195 |
03:18 ET | 100 | 7.22 |
03:20 ET | 500 | 7.2199 |
03:25 ET | 300 | 7.186 |
03:27 ET | 100 | 7.195 |
03:34 ET | 400 | 7.2099 |
03:36 ET | 200 | 7.1963 |
03:38 ET | 1250 | 7.21 |
03:39 ET | 100 | 7.19 |
03:41 ET | 1222 | 7.17 |
03:43 ET | 741 | 7.16 |
03:45 ET | 4553 | 7.15 |
03:48 ET | 400 | 7.14 |
03:50 ET | 2836 | 7.2 |
03:54 ET | 1000 | 7.21 |
03:56 ET | 1117 | 7.22 |
03:57 ET | 710 | 7.22 |
03:59 ET | 20903 | 7.2 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Actinium Pharmaceuticals Inc | 220.4M | -4.2x | --- |
Rezolute Inc | 220.9M | -3.8x | --- |
Greenwich Lifesciences Inc | 222.3M | -23.3x | --- |
Zura Bio Ltd | 222.9M | -2.2x | --- |
Solid Biosciences Inc | 217.6M | -1.6x | --- |
ATAI Life Sciences NV | 222.7M | -5.6x | --- |
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A is a therapeutic agent, have demonstrated potential to extend survival outcomes for people with relapsed and refractory acute myeloid leukemia. The Company focuses on advance Iomab-B for other blood cancers and next generation conditioning candidate Iomab-ACT to improve cell and gene therapy outcomes. The Company holds patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. Actinium-225 is a potent alpha-particle emitter that has high linear energy transfer capable of killing targeted cancer cells via double-strand breaks in DNA.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $220.4M |
---|---|
Revenue (TTM) | $81.0K |
Shares Outstanding | 29.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.20 |
EPS | $-1.72 |
Book Value | $1.32 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 2,721.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -61,645.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.